Join the Seizures group to help and get support from people like you.
Seizures News (Page 3)
Related terms: Complex Partial Seizure, Fits, Convulsion, Absence Seizure
EMS Crews May Not Always Follow Guidelines When Dosing Kids: Study
MONDAY, July 10, 2023 – Less than half of all children treated by emergency medical services receive the right amount of medication during out-of-hospital emergencies, a new study found. In some...
Surgery Offers Survival Benefit for Pediatric Drug-Resistant Epilepsy
TUESDAY, June 20, 2023 – For pediatric patients with drug-resistant epilepsy, vagus nerve stimulation (VNS) or cranial epilepsy surgery offers a survival benefit compared with antiseizure...
Seizures While Driving Highlight Importance of Early Diagnosis of Epilepsy
FRIDAY, June 9, 2023 – Before learning they had epilepsy, about 5% of people who have what's called focal epilepsy had a seizure while driving, new research suggests. “Seizures while driving pose s...
~5 Percent Have Seizure While Driving Prior to Epilepsy Diagnosis
FRIDAY, June 9, 2023 – About 5 percent of people have a seizure while driving (SzWD) prior to being diagnosed with epilepsy, according to a study published online June 7 in Neurology. Benjamin...
Alzheimer's Genes Might Also Raise Odds for Epilepsy
THURSDAY, May 25, 2023 – People with a genetic predisposition to Alzheimer’s disease may have an increased risk of epilepsy, a new study says. And folks with a certain type of epilepsy may have hig...
Causal Link ID'd for Alzheimer Disease, Generalized Epilepsy
THURSDAY, May 25, 2023 – There is a causal link between Alzheimer disease (AD), amyloid pathology, and generalized epilepsy, according to a study published online May 24 in Neurology. Yi Fang, M.D.,...
Prenatal Valproate Exposure Tied to Psychiatric Disorders in Late Childhood
WEDNESDAY, May 24, 2023 – Prenatal exposure to the antiepileptic medication valproate is associated with an increased risk for later psychiatric disorders among children of mothers with epilepsy,...
FDA Approves Sezaby (phenobarbital sodium powder for injection) for the Treatment of Neonatal Seizures
First and only product approved for treating seizures in neonatal patients Mumbai, India, November 18, 2022 – Sun Pharmaceutical Industries Limited and Sun Pharma Advanced Research Company Ltd. t...
FDA Approves Zonisade (zonisamide oral suspension) for the Treatment of Partial-Onset Seizures
The first and only FDA-approved zonisamide oral liquid formulation WOBURN, Mass., July 18, 2022 /PRNewswire/ – Azurity Pharmaceuticals, Inc., a private pharmaceutical company focused on developing...
Fintepla (fenfluramine) Oral Solution Now FDA Approved for Treatment of Seizures Associated with Lennox-Gastaut Syndrome (LGS)
Fintepla® has demonstrated efficacy in the most difficult-to-treat seizure types,1,2 including drop seizures, which cause a person to suddenly lose muscle tone, become limp, and fall to the ground, ...
FDA Approves Ztalmy (ganaxolone) for Seizures Associated with CDKL5 Deficiency Disorder
RADNOR, Pa.--(BUSINESS WIRE)-- Marinus Pharmaceuticals, Inc. (Nasdaq: MRNS), a pharmaceutical company dedicated to the development of innovative therapeutics to treat seizure disorders, today...
FDA Medwatch Alert: Sagent Pharmaceuticals, Inc. Issues Voluntary Nationwide Recall of Levetiracetam Injection, USP Due to Lack of Sterility Assurance
CHICAGO, IL – November 19, 2021 - Sagent Pharmaceuticals, Inc. today announced the voluntary nationwide recall of four lots of Levetiracetam Injection, USP, to the user level. The lack of container c...
UCB Announces Briviact (brivaracetam) Now FDA-Approved to Treat Partial-Onset Seizures in Pediatric Patients One Month of Age and Older
ATLANTA, Aug. 30, 2021 /PRNewswire/ – UCB announced today that the U.S. Food and Drug Administration (FDA) has approved an expanded indication for Briviact (brivaracetam) CV tablets, oral solution,...
Vimpat (lacosamide) Now Approved by FDA for Primary Generalized Tonic-Clonic Seizures and Expanded Pediatric Use for People Living with Epilepsy
ATLANTA, Nov. 17, 2020 /PRNewswire/ – UCB, a global pharmaceutical company, today announced that the U.S. Food and Drug Administration (FDA) has approved Vimpat (lacosamide) CV as adjunctive therapy...
FDA Approves Epidiolex (cannabidiol) Oral Solution to Treat Seizures Associated with Tuberous Sclerosis Complex
CARLSBAD, Calif., Aug. 03, 2020 (GLOBE NEWSWIRE) – GW Pharmaceuticals plc (Nasdaq: GWPH), the world leader in the science, development, and commercialization of cannabinoid prescription medicines,...
Ask a question
To post your own question to this support group, sign in or create an account.
Further information
Related condition support groups
Seizure Prevention, Seizure Prophylaxis, Epilepsy
Related drug support groups
gabapentin, clonazepam, Valium, diazepam, Topamax, pregabalin, lamotrigine, Depakote, topiramate, view more... Keppra, progesterone, Trileptal, oxcarbazepine, levetiracetam, phenobarbital, Vimpat